As of 2025-09-16, the Relative Valuation of Gritstone Oncology Inc (GRTS) is (52.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 USD, the upside of Gritstone Oncology Inc based on Relative Valuation is -161693.6%.
The range of the Relative Valuation is (44.15) - (53.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 20.5x | 18.0x |
| Forward P/E multiples | 16.8x - 26.4x | 21.6x |
| Fair Price | (44.15) - (53.93) | (52.03) |
| Upside | -137209.7% - -167569.7% | -161693.6% |
| Date | P/E |